VOYXACT is the first and only FDA-approved treatment for adults with primary IgAN at risk for disease progression that selectively inhibits A PRoliferation Inducing Ligand (APRIL), a key immune driver ...
Troy Segal is an editor and writer. She has 20+ years of experience covering personal finance, wealth management, and business news. Lea Uradu, J.D., is a Maryland state registered tax preparer, state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results